MTAP and acute lymphoblastic leukemia: In Philadelphia-positive (Ph+) B-ALL adult patients MTAP is co-deleted with the cyclin dependent kinase inhibitor (CDKN)2A gene in 71.4% of cases with 9p21 loss [18].